Top Prefered Stocks To Buy For 2015

With BlackBerry (BBRY) apparently now "in play", you're hearing all the "what-if" scenarios:

*What if Cisco (CSCO) . .

*What if Sony (SNE) . .

*What if Microsoft (MSFT) buys it?

Any of these companies might buy BlackBerry, or none of them. The impact on its stock price is hard to guess in any case. But the road to one possibility is now being tested at Dell (DELL) and founder Michael Dell.

If BlackBerry were taken private, could this mean a return of Research In Motion founder and former Co-CEO, Mike Lazaridis?

Return of the founder

There's talk that Prem Watsa, head of Fairfax Financial Holdings (FRFHF.PK), could possibly be involved in a privatization bid for the company. Consider:

*Watsa's firm owns 10% of BlackBerry.

*Lazaridis holds 5.7%.

*Watsa and Lazaridis are friends.

Lazaridis didn't sell his shares when he stepped down. If BlackBerry is his baby - and doesn't want to see it die - he might be looking to return. If to the board, or an executive position, maybe he could come in as chief technology officer and "overall visionary".

Top Prefered Stocks To Buy For 2015: Orbital Sciences Corporation(ORB)

Orbital Sciences Corporation develops and manufactures small and medium-class rockets and space systems for commercial, military, and civil government customers. The company operates in three segments: Launch Vehicles, Satellites and Space Systems, and Advanced Space Programs. The Launch Vehicles segment develops and produces small-class launch vehicles that place satellites into low-Earth orbit; interceptor launch vehicles for missile defense systems, including interceptor boosters; and target launch vehicles, such as suborbital rockets and their principal subsystems, as well as payloads carried by vehicles used in the development and testing of missile defense systems. The Satellites and Space Systems segment develops and produces communications satellites that provide cable and direct-to-home television distribution, business data network connectivity, regional mobile telephony, and other space-based communications services; and science and remote sensing satellites tha t are used to conduct space-related scientific research, collect imagery and other remotely-sensed data about the Earth, carry out interplanetary and other deep-space exploration missions, and demonstrate new space technologies. This segment also provides space systems and subsystems, including satellite command and data handling, and attitude control and structural subsystems; and a range of space-related technical services, including analytical, engineering, and production services for space-related science and defense programs. The Advanced Space Programs segment develops and produces human-rated systems to be used in earth orbit, planetary exploration, and other space missions; and small and medium-class satellites and related systems used primarily for national security space missions and related technology demonstration programs. It operates in the United States, Europe, Mexico, South America, Australia, and east Asia. The company was founded in 1982 and is headquarter ed in Dulles, Virginia.

Advisors' Opinion:

• [By Jake L'Ecuyer]

  Shares of Orbital Sciences (NYSE: ORB) got a boost, shooting up 19.68 percent to $31.80 after the company and Allian Techsystems' (NYSE: ATK) Aerospace and Defense Groups agreed to combine to create Orbital ATK.

• [By Chris Katje]

  For those unfamiliar with Orbital Sciences (ORB), the company is a leader in space missions and satellite services. The company operates its business in three segments: launch vehicles, satellites and space systems, and advanced space programs. The company's contract with the International Space System, huge backlog, and human space exploration could send shares much higher than current levels.

• [By Lee Jackson]

  Orbital Sciences Corp.‘s (NYSE: ORB) 2013 results and 2014 outlook point to the revenue growth and high free cash flow potential of the franchise. The Jefferies analysts see opportunities for new orders, 7% revenue growth and acceleration of free cash flow, and they expect shares to continue to advance. The company develops and manufactures small and medium-class rockets and space systems for commercial, military and civil government customers. Jefferies raises its price target from $27 to $31. The consensus number is $33.17. The stock closed on Friday at $28.27.

Top Prefered Stocks To Buy For 2015: Sharp Corp (SRP)

Sharp Corporation is a Japan-based company mainly engaged in the manufacture and sale of electric telecommunication, electric and electronic equipment. The Company operates in two business segments. The Electronics Equipment segment offers audio and video (AV) and communication products, including liquid crystal color televisions, projectors and various telephones; health and environmental equipment, including refrigerators, microwaves and air conditioners, as well as information equipment, such as handy terminal equipment, electronic registers, information displays and copy machines. The Electronic Component segment provides liquid related products such as liquid crystal display modules, solar cells, as well as other electronic devices, such as parts for satellite broadcasting, regulators and optical sensors. The Company withdrawed from solar battery production in United Kingdom by end of Feb. 2014. Advisors' Opinion:

• [By Sofia Horta e Costa]

  Vivendi SA climbed 2.7 percent after posting better-than-estimated third-quarter profit and saying it plans to spin off its French phone carrier SFR by July 2014. Serco Group Plc (SRP) increased 1.7 percent as UBS AG upgraded the stock. Safran SA (SAF) lost 3.2 percent as its largest shareholder sold a stake.

• [By Alexis Xydias]

  Eurasian Natural Resources Corp. fell 3.7 percent, as a gauge of London-listed commodity producers dropped. BAE Systems Plc (BA/) retreated 2.1 percent after Deutsche Bank AG downgraded Europe�� biggest defense company. Serco Group Plc (SRP) advanced 2.7 percent after saying first-half sales will grow at a faster pace than it had estimated.

Hot Valued Stocks To Own Right Now: Transmontaigne Partners L.P. (TLP)

TransMontaigne Partners L.P. operates as a terminaling and transportation company. It provides integrated terminaling, storage, transportation, and related services for customers engaged in the distribution and marketing of light refined petroleum products, heavy refined petroleum products, crude oil, chemicals, fertilizers, and other liquid products. The company operates along the Gulf Coast, in the Midwest, in Brownsville, Texas, along the Mississippi and Ohio Rivers, and in the southeastern United States. As of December 31, 2010, it operated 7 refined product terminals in Florida with an aggregate storage capacity of approximately 7.1 million barrels; a 67-mile interstate refined products pipeline between Missouri and Arkansas and 3 refined product terminals with approximately 0.6 million barrels of aggregate active storage capacity; 2 refined product terminals located in Mt. Vernon, Missouri, as well as Rogers, Arkansas with an aggregate active storage capacity of appr oximately 407,000 barrels; and 1 refined product terminal in Oklahoma City, Oklahoma with an aggregate active storage capacity of approximately 158,000 barrels. The company also operated 1 refined product terminal in Brownsville, Texas with an aggregate active storage capacity of approximately 2.2 million barrels; 1 refined product terminal located in Matamoros, Mexico with an aggregate active LPG storage capacity of approximately 7,000 barrels; a pipeline from Brownsville facilities to its terminal in Matamoros, Mexico; 12 refined product terminals along the Mississippi and Ohio rivers with an aggregate active storage capacity of approximately 2.5 million barrels, as well as a dock facility; and 22 refined product terminals along the Colonial and Plantation pipelines with an aggregate active storage capacity of approximately 9.3 million barrels. TransMontaigne GP L.L.C. serves as the general partner of the company. TransMontaigne Partners L.P. was founded in 2005 and is bas ed in Denver, Colorado.

Advisors' Opinion:

• [By Seth Jayson]

  Transmontaigne Partners (NYSE: TLP  ) is expected to report Q2 earnings around July 16. Here's what Wall Street wants to see:

  The 10-second takeaway
  Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Transmontaigne Partners's revenues will increase 5.5% and EPS will compress -23.9%.

• [By Eric Volkman]

  TransMontaigne Partners (NYSE: TLP  ) is drilling into the market to raise in the neighborhood of $60 million. The company has floated 1.45 million of its common units in an underwritten public offering priced at $43.32 per unit. The company's underwriters have also been granted a 30-day purchase option for up to an additional 217,500 units.

Top Prefered Stocks To Buy For 2015: Odyssey Marine Exploration Inc.(OMEX)

Odyssey Marine Exploration, Inc. provides shipwreck exploration services for use in insurance investigations, and search and recovery operations to governments and deep-ocean mineral exploration companies. The company?s shipwreck projects consist of various activities, including research and development, and search operations; archaeological excavation and recovery operations; and conservation, recording, and documentation. It also sells shipwreck findings, including coins and other mass-produced cargo, cultural collections, and replicas to collectors, museums, and other institutions. Odyssey Marine Exploration, Inc. was founded in 1986 and is headquartered in Tampa, Florida.

Advisors' Opinion:

• [By Rich Duprey]

  Despite silver falling to around $23 an ounce, and gold going below $1,400, now might be the time to invest in Odyssey Marine Exploration (NASDAQ: OMEX  ) , the treasure-hunting shipwreck finder whose own stock is down by a third from its 52-week high.

• [By Jonathan Yates]

  Investors around the world are becoming more aware of the potential riches to be made by companies in the sea treasure recovery industry such as J.D. Hutt (PINK JABA) and Odyssey Marine Exploration (NASDAQ: OMEX) due to the media attention being paid to the raising of the Concordia. More than $60 billion rests on the ocean floor in gold (NYSE: GLD), silver (NYSE: SLV), and other valuables. As detailed in a previous article on this site, Odyssey Marine Exploration just presented at the 2013 Gateway Conference.

• [By Sean Williams]

  Odyssey Marine Exploration (NASDAQ: OMEX  )
  I love a good metals play as much as any Fool around here, but Odyssey Marine is certainly not on the buy list. Odyssey Marine is a salvage company that searches for, recovers, and monetizes metals and minerals found on the ocean floor. Make no mistake about it, the job is as cool as it sounds; unfortunately, "cool" doesn't always translate into solid profits.

Top Prefered Stocks To Buy For 2015: Barclays PLC (JO)

Barclays PLC (Barclays) is a global financial services provider engaged in retail banking, credit cards, wholesale banking, investment banking, wealth management and investment management services. The Company�� operations include its overseas offices, subsidiaries and associates. The Company operates in eight segments: UK Retail and Business Banking (UK RBB), Europe Retail and Business Banking (Europe RBB), Africa Retail and Business Banking (Africa RBB), Barclaycard, Barclays Investment Bank, Barclays Corporate Banking, Wealth and Investment Management, and Head Office and Other Operations. Advisors' Opinion:

• [By Sean Williams]

  Time for a cup of joe
  Two years ago I slapped a CAPScall of underperform on the iPath DJ AIG Coffee ETF (NYSEMKT: JO  ) following what looked like a rampant speculative run higher. Coffee stockpiles weren't particularly low back then and there didn't appear to be any weather-related production concerns, so the run-up in coffee futures looked unwarranted. Sure enough, two years later that CAPScall is up nearly 90 points. Now, I'm going to turn that frown upside down and suggest it's the perfect time to consider buying this ETF that closely tracks coffee futures!

Top Prefered Stocks To Buy For 2015: Julius Baer Gruppe AG (BAER)

Julius Baer Gruppe AG (the Group) is a Switzerland-based private banking group, with an exclusive focus on servicing and advising private clients and independent asset managers. The Group has a global presence with approximately 50 locations in more than 25 countries and jurisdictions. Julius Baer Gruppe AG was established through spin off from Julius Baer Holding AG�� businesses into two independent entities, namely the Company, together with its subsidiaries, comprising Bank Julius Baer & Co Ltd as its principal operating entity, and GAM Holding, together with its subsidiaries, comprising GAM and the Julius Baer-branded asset management business, which includes the private label funds business that formerly was part of Julius Baer Holding Ltd�� Bank Julius Baer segment. The Group diversifies its operations into geographical segments, including Switzerland, rest of Europe, Americas, and Asia and Other Countries. Advisors' Opinion:

• [By Corinne Gretler]

  Julius Baer Group Ltd. (BAER) rallied 5.7 percent to 42.04 francs. Switzerland�� third-biggest wealth manager said increased client trading boosted margins as it integrated Merrill Lynch businesses acquired from Bank of America Corp. last year. The gross margin, which reflects how much the bank makes in revenue on managed client assets, rose to 102 basis points in the first half, from 98 basis points in the year-earlier period.

Top Prefered Stocks To Buy For 2015: Pactera Technology International Ltd (PACT)

Pactera Technology International Ltd. (Pactera), formerly HiSoft Technology International Limited, incorporated on May 27, 2004, provides global consulting and technology services. The Company provides business/information technology (IT) consulting, solutions, and outsourcing services to a range of multinational firms through a globally integrated network of onsite and offsite delivery locations in China, the United States, Europe, Australia, Japan, Singapore and Malaysia. In January 2014, Pactera Technology International Ltd announced the acquisition of Innoveo Solutions AG.

The Company�� services include business and technology advisory, enterprise application services, business intelligence, application development and maintenance, mobility, cloud computing, infrastructure management, software product engineering and globalization, and business process outsourcing. The Company�� clients include 3M, ABB, Cathay Pacific, China Merchants Bank, Citibank, EMC, Expedia, GE, HP, IBM, Lenovo, Microsoft, Mitsubishi, NEC and TIBCO.

Advisors' Opinion:

• [By Seth Jayson]

  Calling all cash flows
  When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on Pactera Technology International (Nasdaq: PACT  ) , whose recent revenue and earnings are plotted below.

Top Prefered Stocks To Buy For 2015: Prothena Corporation PLC (PRTA)

Prothena Corporation PLC, incorporated on September 26, 2012, is an Ireland-based, clinical-stage biotechnology company. The Company is engaged in discovering and developing monoclonal antibodies that are directed towards misfolded proteins or improper cell adhesion. Its pipeline includes NEOD001, PRX002 and PRX003. The Company�� work in protein misfolding could result in therapies to treat several neurodegenerative diseases, including AL (primary) and AA (secondary) forms of amyloidosis (NEOD001), Parkinson's disease and related synucleinopathies (PRX002). Its cell adhesion development activities could generate new therapies to treat inflammatory diseases and metastatic cancers (PRX003). The Company�� program, NEOD001, is in Phase 1. In addition to antibodies directed to neo-epitope targets, it is developing antibodies directed to other targets. The Company has generated antibodies against cell adhesion targets expressed on certain pathogenic Th17 immune cells and tumor cells.

The Company�� pipeline also includes several late discovery stage programs for which it is testing antibodies in preclinical models of disease. It is also generating additional antibodies against other targets involved in protein misfolding and cell adhesion for characterization in vivo and in vitro.

NEOD001 for Amyloidosis

NEOD001 is a monoclonal antibody that targets the amyloid that accumulates in both AL and AA forms of amyloidosis. The antibody was designed to not react with normal serum amyloid A and only with the aberrant cleaved form of the protein (amyloid A).

PRX002 for Parkinson�� Disease

The Company has generated antibodies targeting alpha-synuclein that may slow or reduce the neurodegeneration associated with synuclein misfolding and/or transmission. It has tested these antibodies in various cellular and animal models of synuclein-related disease. In a transgenic mouse model of Parkinson�� disease, passive immunization with 9E4, a murine ver! sion of PRX002, reduced the appearance of synuclein pathology, protected synapses and improved performance by the mice in behavioral testing. The humanized antibody product candidate PRX002 has advanced into manufacturing and preclinical testing.

PRX003 for Inflammatory Diseases and Cancers

The Company is developing PRX003, a monoclonal antibody targeting MCAM for the potential treatment of inflammatory diseases and cancers. It has generated monoclonal antibodies that block MCAM-mediated cell adhesion and have been shown to delay relapse and severity of relapse in a mouse model of multiple sclerosis known as experimental autoimmune encephalomyelitis. The Company�� antibodies are being tested in animal models of inflammatory diseases and cancers. Based on early results from these studies, it has identified a clinical candidate, PRX003. It has advanced this antibody into manufacturing and intends to advance this antibody into preclinical testing.

Advisors' Opinion:

• [By Jake L'Ecuyer]

  Prothena Corporation (NASDAQ: PRTA) shares were down as well, falling 28.00 percent to $27.13 after the company released some materials from its coming symposium presentation.

• [By Lisa Levin]

  Prothena Corporation plc (NASDAQ: PRTA) shares surged 23.52% to touch a new 52-week high of $45.90 after the company reported clinical data to be presented at International Symposium on Amyloidosis. Morgan Stanley raised the price target on the stock from $35.00 to $53.00.